Perspective Therapeutics, Inc. (CATX) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 76K | 0 | 209K | 290K | 0 | 0 | 0 | 0 | 0 | 337K | 1.91M | 1.5M | 1.83M | 1.83M | 1.72M | 2.5M | 2.91M | 2.82M | 2.56M | 2.71M |
| Revenue Growth % | - | - | - | - | - | -100% | -100% | -100% | -100% | -81.63% | 11.18% | -40.12% | -37.11% | -34.84% | -33.03% | -7.56% | 11.92% | 19.37% | 7.55% | 18.91% |
| Cost of Goods Sold | 1.13M | 0 | 775K | 733K | 0 | 0 | 0 | 0 | 0 | 0 | 1.45M | 1.84M | 1.58M | 1.43M | 1.3M | 1.58M | 1.47M | 1.6M | 1.53M | 1.36M |
| COGS % of Revenue | 1481.58% | - | 370.81% | 252.76% | - | - | - | - | - | - | 75.8% | 122.67% | 86.12% | 78.04% | 75.89% | 63.03% | 50.48% | 56.68% | 59.87% | 50.33% |
| Gross Profit | -1.05M | 0 | -566K | -443K | 0 | 0 | 0 | 0 | 0 | 337K | 462K | -340K | 254K | 403K | 414K | 926K | 1.44M | 1.22M | 1.03M | 1.35M |
| Gross Margin % | -1381.58% | - | -270.81% | -152.76% | - | - | - | - | - | 100% | 24.2% | -22.67% | 13.88% | 21.96% | 24.11% | 36.97% | 49.52% | 43.32% | 40.13% | 49.67% |
| Gross Profit Growth % | - | - | - | - | - | -100% | -100% | 100% | -100% | -16.38% | 11.59% | -136.72% | -82.37% | -66.97% | -59.77% | -31.2% | 5.8% | 4.54% | -17.42% | 25.68% |
| Operating Expenses | 27.23M | 39.83M | 27.3M | 23.6M | 21.83M | 46.44M | 18.63M | 14.26M | 13.01M | 2.57M | 11M | 11.03M | 11.46M | 3.61M | 4.62M | 3.03M | 2.82M | 2.85M | 3.3M | 2.44M |
| OpEx % of Revenue | 35830.26% | - | 13059.81% | 8136.55% | - | - | - | - | - | 761.72% | 576.01% | 735.6% | 626.17% | 196.51% | 269.19% | 121.04% | 96.8% | 101.38% | 128.82% | 90% |
| Selling, General & Admin | 6.99M | 6.95M | 7.73M | 7.71M | 7.84M | 8.25M | 6.97M | 5.51M | 5.88M | 1.69M | 5.55M | 5.98M | 7.83M | 2.99M | 3.91M | 2.24M | 2.27M | 2.32M | 2.6M | 1.97M |
| SG&A % of Revenue | 9190.79% | - | 3699.04% | 2658.28% | - | - | - | - | - | 502.67% | 290.78% | 398.93% | 428.14% | 163.11% | 227.96% | 89.26% | 77.94% | 82.39% | 101.44% | 72.73% |
| Research & Development | 20.25M | 32.92M | 20.34M | 12.17M | 14.33M | 12.88M | 12.03M | 9.28M | 7.45M | 6.08M | 5.72M | 5.65M | 3.86M | 613K | 708K | 796K | 549K | 535K | 702K | 468K |
| R&D % of Revenue | 26639.47% | - | 9731.58% | 4197.93% | - | - | - | - | - | 1804.15% | 299.69% | 376.87% | 210.77% | 33.41% | 41.23% | 31.78% | 18.87% | 19% | 27.38% | 17.27% |
| Other Operating Expenses | 0 | -43K | -775K | 1000K | -342K | 1000K | 0 | 0 | -325K | -1000K | 0 | 2K | -233K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -28.28M | -39.83M | -27.86M | -24.04M | -21.83M | -44.98M | -18.63M | -14.26M | -13.01M | -7.81M | -10.53M | -11.37M | -11.21M | -3.2M | -4.21M | -2.11M | -1.21M | -1.64M | -2.27M | -1.09M |
| Operating Margin % | -37211.84% | - | -13330.62% | -8289.31% | - | - | - | - | - | -2316.32% | -551.81% | -758.27% | -612.3% | -174.55% | -245.08% | -84.07% | -41.48% | -58.06% | -88.69% | -40.33% |
| Operating Income Growth % | -29.54% | 11.45% | -49.52% | -68.54% | -67.87% | -476.27% | -76.89% | -25.4% | -16.06% | -143.71% | -150.33% | -440.08% | -828.33% | -95.9% | -85.05% | -92.68% | -57.57% | -87.29% | -218.49% | 8.07% |
| EBITDA | -27.16M | -38.82M | -27.09M | -23.31M | -21.1M | -44.26M | -17.96M | -13.69M | -12.66M | -7.54M | -10.28M | -11.13M | -10.65M | -3.1M | -4.14M | -2.04M | -1.38M | -1.57M | -2.21M | -1.05M |
| EBITDA Margin % | -35730.26% | - | -12959.81% | -8036.55% | - | - | - | - | - | -2238.58% | -538.24% | -741.93% | -582.02% | -169.21% | -241.12% | -81.48% | -47.29% | -55.93% | -86.39% | -38.78% |
| EBITDA Growth % | -28.7% | 12.29% | -50.77% | -70.2% | -66.68% | -486.73% | -74.84% | -23.04% | -18.85% | -142.96% | -148.19% | -445.27% | -674.06% | -97.14% | -86.91% | -94.2% | -88.49% | -88.4% | -225.74% | 9% |
| D&A (Non-Cash Add-back) | 1.13M | 1.01M | 775K | 733K | 732K | 721K | 669K | 570K | 346K | 262K | 259K | 245K | 554K | 98K | 68K | 65K | -169K | 60K | 59K | 42K |
| EBIT | -28.28M | -38.22M | -25.9M | -21.88M | -18.05M | -42.34M | -15.05M | -11.25M | -11.79M | -8.85M | 0 | -11.37M | -11.21M | -3.2M | 0 | 0 | -1.21M | 0 | -2.27M | 0 |
| Net Interest Income | 2.09M | 1.55M | 1.89M | 2.04M | 2.26M | 2.72M | 3.51M | 3.05M | 1.18M | 38K | 190K | 268K | 356K | 0 | 0 | 28K | 29K | 31K | 31K | 32K |
| Interest Income | 2.2M | 1.61M | 1.96M | 2.16M | 2.38M | 2.65M | 3.58M | 3.08M | 1.21M | 62K | 204K | 294K | 374K | 400K | 140K | 28K | 29K | 31K | 31K | 32K |
| Interest Expense | 105K | 64K | 65K | 119K | 128K | -73K | 69K | 23K | 29K | 24K | 14K | 26K | 18K | 400K | 140K | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 2.09M | 1.55M | 1.89M | 2.04M | 3.65M | 2.72M | 3.51M | 2.99M | 1.18M | -1.06M | -12K | 2K | 334K | 302K | 140K | 28K | -140K | 28K | 29K | 574K |
| Pretax Income | -26.19M | -38.28M | -25.97M | -22M | -18.18M | -42.27M | -15.12M | -11.28M | -11.82M | -8.87M | -10.08M | -11.11M | -10.87M | -2.9M | -4.07M | -2.08M | -1.35M | -1.6M | -2.24M | -1.06M |
| Pretax Margin % | -34459.21% | - | -12425.36% | -7585.86% | - | - | - | - | - | -2632.05% | -528.03% | -740.4% | -594.04% | -158.09% | -236.92% | -82.95% | -46.29% | -56.96% | -87.48% | -39.15% |
| Income Tax | 0 | -793K | 0 | 0 | 0 | -2.1M | 0 | -61K | 0 | 7.85M | 278K | -215K | -10.5M | -702K | -140K | -65K | -140K | -28K | -29K | -574K |
| Effective Tax Rate % | 0% | 2.07% | 0% | 0% | 0% | 4.96% | 0% | 0.54% | 0% | -88.49% | -2.76% | 1.94% | 96.59% | 24.2% | 3.44% | 3.13% | 10.39% | 1.75% | 1.29% | 54.1% |
| Net Income | -26.19M | -37.49M | -25.97M | -21.48M | -18.18M | -40.17M | -15.12M | -11.7M | -12.28M | -24.68M | -10.36M | -11.11M | -371K | -2.2M | -3.93M | -2.01M | -1.21M | -1.6M | -2.24M | -1.06M |
| Net Margin % | -34459.21% | - | -12425.36% | -7408.62% | - | - | - | - | - | -7321.96% | -542.48% | -740.4% | -20.27% | -119.84% | -228.77% | -80.36% | -41.48% | -56.96% | -87.48% | -39.15% |
| Net Income Growth % | -44.08% | 6.67% | -71.73% | -83.57% | -47.97% | -62.79% | -46.02% | -5.38% | -3211.05% | -1022.1% | -163.65% | -451.71% | 69.26% | -37.09% | -75.12% | -89.73% | -62.01% | -84.79% | -214.59% | 10.69% |
| Net Income (Continuing) | -26.19M | -37.49M | -25.97M | -22M | -18.18M | -40.11M | -15.12M | -11.21M | -11.82M | -16.72M | - | - | -371K | -2.2M | -3.93M | -2.01M | -1.21M | - | - | - |
| Discontinued Operations | 0 | 0 | 0 | 514K | 0 | 0 | 0 | -429K | -461K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.25 | -0.51 | -0.35 | -0.30 | -0.25 | -0.57 | -0.21 | -0.18 | -0.25 | -0.45 | -0.19 | -0.20 | -0.01 | -0.04 | -0.07 | -0.04 | -0.02 | -0.03 | -0.04 | -0.02 |
| EPS Growth % | 0% | 10.53% | -66.67% | -66.67% | 0% | -26.67% | -10.53% | 10% | - | -1022.19% | -165.73% | -444.96% | 69.09% | -37.33% | -74.82% | -90.16% | -61.76% | -178.1% | -297.09% | -10.29% |
| EPS (Basic) | -0.25 | -0.51 | -0.35 | -0.30 | -0.25 | -0.57 | -0.21 | -0.18 | -0.25 | -0.45 | -0.19 | -0.20 | -0.01 | -0.04 | -0.07 | -0.04 | -0.02 | -0.03 | -0.04 | -0.02 |
| Diluted Shares Outstanding | 103.6M | 73.81M | 74.3M | 70.67M | 72.36M | 70.63M | 70.63M | 66.65M | 49.51M | 54.91M | 54.91M | 54.91M | 54.91M | 54.91M | 54.91M | 54.91M | 54.91M | 54.91M | 54.91M | 54.91M |
| Basic Shares Outstanding | 103.6M | 73.81M | 74.3M | 70.67M | 72.36M | 70.63M | 70.63M | 66.65M | 49.51M | 54.91M | 54.91M | 54.91M | 54.91M | 54.91M | 54.91M | 54.91M | 54.91M | 54.91M | 54.91M | 54.91M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |